Background Multidrug-resistant Acinetobacter baumannii remains challenging to treat.
Although eravacycline has in vitro activity against this pathogen, there are no studies …

This study investigated the in vitro activity of colistin or sulbactam in combination with
fosfomycin or imipenem against eight strains of carbapenemresistant A. baumannii (CRAB) …

OBJECTIVES: The incidence of multi-drug-resistant (MDR) Acinetobacter strains is
increasing and therapeutic options are limited. However, controversy exists regarding the …

Nachdem die letzten Jahrzehnte durch eine zunehmende Ausbreitung grampositiver
nosokomialer Infektionserreger gekennzeichnet waren, zeichnet sich in den letzten Jahren …

Objective. To investigate the mode of transmission of imipenem-resistant Acinetobacter
baumannii strains causing episodes of sepsis. Setting. A 7-bed trauma intensive care unit …

Increasing appreciation of the role of Acinetobacter baumannii in the aetiology of severe
nosocomial infections, together with its ability to employ several mechanisms to rapidly …

OBJECTIVES: Our objective was to compare the virulence of 5 strains of Acinetobacter
baumannii by using a mouse model of pneumonia. METHODS: Six-week old female …

Objectives To investigate the clinical impact of different genospecies of the Acinetobacter
calcoaceticus–Acinetobacter baumannii complex (ACB complex; A. baumannii …

Acinetobacter baumannii is a nosocomial pathogen increasingly affecting the critically ill
patients and represents a major public health challenge. Carbapenem-resistant A …

BACKGROUND: Infections due to carbapenem-resistant Enterobacteriaceae have been the
emerging problem worldwide. This primary object of this study was to understand the risk …